18-675346-T-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_017512.7(ENOSF1):āc.1205A>Cā(p.Gln402Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000062 in 1,612,588 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_017512.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ENOSF1 | NM_017512.7 | c.1205A>C | p.Gln402Pro | missense_variant | 15/16 | ENST00000647584.2 | NP_059982.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ENOSF1 | ENST00000647584.2 | c.1205A>C | p.Gln402Pro | missense_variant | 15/16 | NM_017512.7 | ENSP00000497230 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152214Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000805 AC: 2AN: 248572Hom.: 0 AF XY: 0.0000149 AC XY: 2AN XY: 134148
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1460374Hom.: 0 Cov.: 30 AF XY: 0.00000689 AC XY: 5AN XY: 726212
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152214Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74358
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 19, 2023 | The c.1226A>C (p.Q409P) alteration is located in exon 14 (coding exon 14) of the ENOSF1 gene. This alteration results from a A to C substitution at nucleotide position 1226, causing the glutamine (Q) at amino acid position 409 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at